目次

Table of Contents

1. EXECUTIVE SUMMARY
　1. Market Overview
　2. Key Findings
　3. Market Segmentation
　4. Competitive Landscape
　5. Challenges and Opportunities
　6. Future Outlook

1. MARKET INTRODUCTION
　1. Definition
　2. Scope of the study
　　1. Research Objective
　　2. Assumption
　　3. Limitations

2. RESEARCH METHODOLOGY
　1. Overview
　2. Data Mining
　3. Secondary Research
　4. Primary Research
　　1. Primary Interviews and Information Gathering Process
　　2. Breakdown of Primary Respondents
　5. Forecasting Model
　6. Market Size Estimation
　　1. Bottom-Up Approach
　　2. Top-Down Approach
　7. Data Triangulation
　8. Validation

1. MARKET DYNAMICS
　1. Overview
　2. Drivers
　3. Restraints
　4. Opportunities

2. MARKET FACTOR ANALYSIS
　1. Value chain Analysis
　2. Porter's Five Forces Analysis
　　1. Bargaining Power of Suppliers
　　2. Bargaining Power of Buyers
　　3. Threat of New Entrants
　　4. Threat of Substitutes
　　5. Intensity of Rivalry
　3. COVID-19 Impact Analysis
　　1. Market Impact Analysis
　　2. Regional Impact
　　3. Opportunity and Threat Analysis

1. Japan Generic Pharmaceuticals Market, BY Type (USD Billion)
　1. Simple Generics
　2. Specialty Generics
　3. Biosimilars

2. Japan Generic Pharmaceuticals Market, BY Application (USD Billion)
　1. Central Nervous System Disorders
　2. Respiratory Diseases
　3. Hormones Related Diseases
　4. Gastrointestinal Diseases
　5. Cardiovascular Diseases
　6. Infectious Diseases
　7. Cancer
　8. Diabetes
　9. Others

3. Japan Generic Pharmaceuticals Market, BY Product (USD Billion)
　1. Small Molecule
　2. Large Molecule

4. Japan Generic Pharmaceuticals Market, BY Route of Administration (USD Billion)
　1. Oral
　2. Injectable
　3. Inhalable
　4. Others

5. Japan Generic Pharmaceuticals Market, BY Distribution Channel (USD Billion)
　1. Online Pharmacies
　2. Retail Pharmacies
　3. Hospital Pharmacies

1. Competitive Landscape
　1. Overview
　2. Competitive Analysis
　3. Market share Analysis
　4. Major Growth Strategy in the Generic Pharmaceuticals Market
　5. Competitive Benchmarking
　6. Leading Players in Terms of Number of Developments in the Generic Pharmaceuticals Market
　7. Key developments and growth strategies
　　1. New Product Launch/Service Deployment
　　2. Merger Acquisitions
　　3. Joint Ventures
　8. Major Players Financial Matrix
　　1. Sales and Operating Income
　　2. Major Players RD Expenditure. 2023

2. Company Profiles
　1. Meiji Seika Pharma
　　1. Financial Overview
　　2. Products Offered
　　3. Key Developments
　　4. SWOT Analysis
　　5. Key Strategies
　2. Chugai Pharmaceutical
　　1. Financial Overview
　　2. Products Offered
　　3. Key Developments
　　4. SWOT Analysis
　　5. Key Strategies
　3. Mylan N.V.
　　1. Financial Overview
　　2. Products Offered
　　3. Key Developments
　　4. SWOT Analysis
　　5. Key Strategies
　4. Daiichi Sankyo
　　1. Financial Overview
　　2. Products Offered
　　3. Key Developments
　　4. SWOT Analysis
　　5. Key Strategies
　5. Eisai
　　1. Financial Overview
　　2. Products Offered
　　3. Key Developments
　　4. SWOT Analysis
　　5. Key Strategies
　6. Mitsubishi Tanabe Pharma
　　1. Financial Overview
　　2. Products Offered
　　3. Key Developments
　　4. SWOT Analysis
　　5. Key Strategies
　7. Rakuten Medical
　　1. Financial Overview
　　2. Products Offered
　　3. Key Developments
　　4. SWOT Analysis
　　5. Key Strategies
　8. Takeda Pharmaceutical Company
　　1. Financial Overview
　　2. Products Offered
　　3. Key Developments
　　4. SWOT Analysis
　　5. Key Strategies
　9. Aurobindo Pharma
　　1. Financial Overview
　　2. Products Offered
　　3. Key Developments
　　4. SWOT Analysis
　　5. Key Strategies
　10. Sandoz
　　1. Financial Overview
　　2. Products Offered
　　3. Key Developments
　　4. SWOT Analysis
　　5. Key Strategies
　11. Nippon Chemical Industrial
　　1. Financial Overview
　　2. Products Offered
　　3. Key Developments
　　4. SWOT Analysis
　　5. Key Strategies
　12. Ono Pharmaceutical
　　1. Financial Overview
　　2. Products Offered
　　3. Key Developments
　　4. SWOT Analysis
　　5. Key Strategies
　13. Towa Pharmaceutical
　　1. Financial Overview
　　2. Products Offered
　　3. Key Developments
　　4. SWOT Analysis
　　5. Key Strategies
　14. Kissei Pharmaceutical
　　1. Financial Overview
　　2. Products Offered
　　3. Key Developments
　　4. SWOT Analysis
　　5. Key Strategies
　15. Teva Pharmaceutical Industries
　　1. Financial Overview
　　2. Products Offered
　　3. Key Developments
　　4. SWOT Analysis
　　5. Key Strategies

3. Appendix
　1. References
　2. Related Reports

LIST Of tables
1. LIST OF ASSUMPTIONS
2. Japan Generic Pharmaceuticals Market SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD Billions)
3. Japan Generic Pharmaceuticals Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
4. Japan Generic Pharmaceuticals Market SIZE ESTIMATES & FORECAST, BY PRODUCT, 2019-2035 (USD Billions)
5. Japan Generic Pharmaceuticals Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)
6. Japan Generic Pharmaceuticals Market SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD Billions)
7. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
8. ACQUISITION/PARTNERSHIP

LIST Of figures
1. MARKET SYNOPSIS
2. JAPAN GENERIC PHARMACEUTICALS MARKET ANALYSIS BY TYPE
3. JAPAN GENERIC PHARMACEUTICALS MARKET ANALYSIS BY APPLICATION
4. JAPAN GENERIC PHARMACEUTICALS MARKET ANALYSIS BY PRODUCT
5. JAPAN GENERIC PHARMACEUTICALS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
6. JAPAN GENERIC PHARMACEUTICALS MARKET ANALYSIS BY DISTRIBUTION CHANNEL
7. KEY BUYING CRITERIA OF GENERIC PHARMACEUTICALS MARKET
8. RESEARCH PROCESS OF MRFR
9. DRO ANALYSIS OF GENERIC PHARMACEUTICALS MARKET
10. DRIVERS IMPACT ANALYSIS: GENERIC PHARMACEUTICALS MARKET
11. RESTRAINTS IMPACT ANALYSIS: GENERIC PHARMACEUTICALS MARKET
12. SUPPLY / VALUE CHAIN: GENERIC PHARMACEUTICALS MARKET
13. GENERIC PHARMACEUTICALS MARKET, BY TYPE, 2024 (% SHARE)
14. GENERIC PHARMACEUTICALS MARKET, BY TYPE, 2019 TO 2035 (USD Billions)
15. GENERIC PHARMACEUTICALS MARKET, BY APPLICATION, 2024 (% SHARE)
16. GENERIC PHARMACEUTICALS MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)
17. GENERIC PHARMACEUTICALS MARKET, BY PRODUCT, 2024 (% SHARE)
18. GENERIC PHARMACEUTICALS MARKET, BY PRODUCT, 2019 TO 2035 (USD Billions)
19. GENERIC PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
20. GENERIC PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION, 2019 TO 2035 (USD Billions)
21. GENERIC PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
22. GENERIC PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, 2019 TO 2035 (USD Billions)
23. BENCHMARKING OF MAJOR COMPETITORS